Blue Trust Inc’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Blue Trust Inc's AMPH Position: Q3 2026 in Review
Blue Trust Inc reduced its Amphastar Pharmaceuticals (AMPH) stake by 21% in Q3 2026, selling an estimated $5.64K and leaving 1,012 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.
Blue Trust Inc first reported a position in AMPH in Q2 2022 and has held it in 18 quarters since. The position peaked at $70.4K in Q2 2024. 46 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Blue Trust Inc held 1,012 shares of Amphastar Pharmaceuticals worth $26.1K as of Q3 2026.
- Blue Trust Inc sold 261 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $5.64K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #1427 holding.
- Blue Trust Inc first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
- Blue Trust Inc's Amphastar Pharmaceuticals position peaked at $70.4K in Q2 2024.
- 46 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.